期刊文献+

纳米磁分离实时荧光PCR定量检测登革2型病毒 被引量:2

Development of a new quantitative PCR assay of using magnetic nanoparticles separation for detection of Dengue virus 2 type
原文传递
导出
摘要 目的建立一种登革2型病毒的快速提取和检测的方法。方法根据登革2型病毒的基因保守区,设计一套特异的实时荧光PCR的引物与探针,设计一对引物用于构建定量检测的标准品,以建立登革2型病毒实时荧光定量PCR检测方法;选用纳米磁微粒,建立纳米磁分离提取登革2型病毒RNA的方法,并对其核酸提取效果进行评估。结果纳米磁分离实时荧光PCR方法检测登革2型病毒具有快速、灵敏、特异的特点。在2.9×102~2.9×109copies/μl的范围内循环阀值(C)t值与病毒拷贝数的对数值存在线性关系(R2=0.99)。结论建立的纳米磁分离实时荧光定量PCR方法能够快速准确地检测登革2型病毒,在口岸卫生检疫中具有很好的应用价值。 Objective To establish a real-time RT-qPCR assay of using magnetic nanoparticles for rapid isolation and detection of DV-2. Methods Sets of primers and probe were designed based on the conserved region of the E glycoprotein of DV-2 genome. The standard curve for quantification was set up for DV-2 detection. The method based magnetic nanoparticles was established to isolate nucleic acid of DV-2, and its effect of nucleic acid separation was evaluated. Results The real-time PCR assay using magnetic nanoparticles separation was showed high sensitivity and specificity in detection of DV-2. The relationship between threshold cycle (C,) and logarithm of initial viral copies was linear over a range of 2.9×10^2 to 2.9×10^9 copies/μl of DV-2 (R2= 0.99). Conclusion This method represents a sensitive, specific, rapid approach to detect on DV-2 in clinical specimens.These results suggest that this technique may be useful in early stage diagnosis of dengue infections at entry-exit frontier ports.
出处 《中国国境卫生检疫杂志》 CAS 2013年第3期145-149,172,共6页 Chinese Journal of Frontier Health and Quarantine
基金 国家重大科学研究计划项目(2011CB932803) 国家质检总局科研基金项目(2010IK210)
关键词 磁性纳米微粒 实时荧光PCR 登革2型病毒 Magnetic nanoparticles Real-time qPCR DV-2
  • 相关文献

参考文献14

二级参考文献86

共引文献73

同被引文献20

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
  • 2Sakai NS, Samia - A|y E, Barbera M, et al. A review of the cur- rent understanding and clinical utility of miRNAs in esophageal cancer[J]. Semin Cancer Biol, 2013, 23(6 Pt B) : 512 -521. .
  • 3Ma J, Liu S, Wang Y. MicroRNA -21 and multiple myeloma: small molecule and big function[J]. Med Oncol, 2014, 31 (8): 94.
  • 4Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regu- lator of oncogenic processes [J].Biochem Soc Trans, 2009, 37 (Pt4) : 918 -925.
  • 5Tanaka Y, Kamohara I-I, Kinoshita K, et al. Clinical impact of se- rum exosomal microRNA- 21 as a clinical biomarker in human e- sophageal squamous ceil carcinoma [ J]. Cancer, 2013, 119 (6) : 1159 - 1167.
  • 6Cai EH, Gao YX, Wei ZZ, et al. Serum miR -21 expression in human esophageal squamous cell carcinomas [ J ]. Asian Pac J Cancer Prey, 2012, 13(4) : 1563 - 1567.
  • 7Mahmoudi M, Sant S, Wang B, et al. Superparamagnetic iron ox- ide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy [J].Adv Drug Deliv Rev, 2011, 63(1/2) : 24 -46.
  • 8Sun N, Deng C, Liu Y, et al. Optimization of influencing factors of nucleic acid adsorption onto silica - coated magnetic particles: application to viral nucleic acid extraction from serum[J].J Chro- matogr A, 2014, 1325:31 -39.
  • 9Komatsu S, Ichikawa D, Takeshita H, et ah Circulating microR- NAs in plasma of patients with oesophageal squamous cell carcino- ma[J]. BrJCancer, 2011, 105(1): 104-111.
  • 10Zhang HL, Yang LF, Zhu Y, et ah Serum raiRNA -21 : elevated levels in patients with metastatic hormone - refractory prostate cancer and potential predictive factor for the efficacy of docetaxel - based chemotherapy[ J]. Prostate, 2011,71 (3) : 326 - 331.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部